Rani Therapeutics Holdings, Inc. (RANI) › Operating IncomeRani Therapeutics Holdings, Inc. (RANI) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2020: -$16.54M2021: -$51.60M2022: -$63.45M2023: -$66.10M2024: -$53.31M2025: -$38.31M-$38.31M2020Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$38.31M+28.1%2024-$53.31M+19.3%2023-$66.10M-4.2%2022-$63.45M-23.0%2021-$51.60M-211.9%2020-$16.54M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share